Litcius/Paper detail

FDA rejects NASH drug

Asher Mullard

2020Nature Reviews Drug Discovery24 citationsDOI

Topics & Concepts

DrugDrug approvalPharmacologyMedicineMelanoma and MAPK PathwaysColorectal Cancer Treatments and StudiesSynthesis and biological activity
FDA rejects NASH drug | Litcius